Evidence map›Paper›PMID 26286750›Full record

ArticleThe Journal of biological chemistry2015

The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.

Christa Litschko, Maria Rosaria Romano, Vittoria Pinto, Heike Claus, Ulrich Vogel, Francesco Berti, Rita Gerardy-Schahn, Timm Fiebig

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Cryo-EM analysis ofScience advances · 2024
    Article
  4. Article
  5. Article
  6. Nucleotide Sugars in Chemistry and Biology.Molecules (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Christa LitschkoFrom the Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany.
Maria Rosaria RomanoResearch, GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy, and.
Vittoria PintoResearch, GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy, and.
Heike Clausthe Institute for Hygiene and Microbiology, University of Würzburg, 97080 Würzburg, Germany.
Ulrich Vogelthe Institute for Hygiene and Microbiology, University of Würzburg, 97080 Würzburg, Germany.
Francesco BertiResearch, GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy, and.
Rita Gerardy-SchahnFrom the Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany.
Timm FiebigFrom the Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany, Fiebig.Timm@mh-hannover.de.
Medizinische Hochschule Hannover · DEToscana Life Sciences · ITUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis is a human pathogen causing bacterial meningitis and sepsis. The capsular polysaccharide surrounding N. meningitidis is a major virulence factor. The capsular polysaccharide consists of polyhexosamine phosphates in N. meningitidis serogroups A and X. The capsule polymerases (CPs) of these serogroups are members of the Stealth protein family comprising d-hexose-1-phosphate transferases from bacterial and protozoan pathogens. CslA, one of two putative CPs of the pathophysiologically less relevant N. meningitidis serogroup L, is one of the smallest known Stealth proteins and caught our attention for structure-function analyses. Because the N. meningitidis serogroup L capsule polymer consists of a trimeric repeating unit ([→3)-β-d-GlcNAc-(1→3)-β-d-GlcNAc-(1→3)-α-d-GlcNAc-(1→OPO3→]n), we speculated that the two predicted CPs (CslA and CslB) work together in polymer production. Consequently, both enzymes were cloned, overexpressed, and purified as recombinant proteins. Contrary to our expectation, enzymatic testing identified CslB to be sufficient to catalyze the synthesis of the complex trimeric N. meningitidis serogroup L capsule polymer repeating unit. No polymerase activity was detected for CslA, although the enzyme facilitated the hydrolysis of UDP-GlcNAc. Bioinformatics analyses identified two glycosyltransferase (GT) domains in CslB. The N-terminal domain modeled with 100% confidence onto a number of GT-A folded proteins, whereas the C-terminal domain modeled with 100% confidence onto TagF, a GT-B folded teichoic acid polymerase from Staphylococcus epidermidis. Amino acid positions known to have critical catalytic functions in the template proteins were conserved in CslB, and their point mutation abolished enzyme activity. CslB represents an enzyme of so far unique complexity regarding both the catalyzed reaction and enzyme architecture.

Indexed as

Bacterial CapsulesBacterial ProteinsCarbohydrate SequenceCatalysisCloning, MolecularComputational BiologyEpitopesEstersGlycoside HydrolasesGlycosidesHydrolysisMolecular Sequence DataMutationNeisseria meningitidisPhosphorylationPolymersBacterial Proteinscapsular-polysaccharide galactohydrolaseCDP glycerol glycerophosphotransferaseEpitopesEstersGlycoside HydrolasesGlycosidesPolymersPolysaccharidesRecombinant ProteinsTransferases (Other Substituted Phosphate Groups)bifunctional enzymecapsule polymeraseCslBglycosyltransferasehexose-1-phosphate transferasehigh-performance liquid chromatography (HPLC)Neisseria meningitidisnuclear magnetic resonance (NMR)polysacchariderecombinant protein expression

Identifiers

PMID26286750
PMCPMC4591819
OpenAlexW2150754166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.